paclitaxel has been researched along with Febrile Neutropenia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abbas, MN; Karapetis, CS; Kichenadasse, G; Koczwara, B; Kumar, R; Leung, J; Price, TJ; Roy, AC; Scott-Hoy, A; Singhal, N; Sukumaran, S; Vatandoust, S; Woodman, R | 1 |
| Nara, K; Seto, Y; Suzuki, H; Takada, T; Yagi, K; Yamamoto, T; Yamashita, H | 1 |
| Cha, HS; Hwang, JH; Kim, J; Kim, JW; Kim, MJ; Lee, JC; Lee, WJ; Park, P; Shin, DW; Woo, SM; Yang, SY | 1 |
| Akita, H; Asukai, K; Ioka, T; Ishikawa, O; Ohue, M; Takahashi, H; Tomokoni, A; Wada, H; Yano, M | 1 |
| Crawford, J; Dale, DC; Lyman, GH; Tomita, D; Whittaker, S | 1 |
| Biondo, A; Cassier, PA; Chen, E; de Bono, JS; Minton, S; Molife, LR; Papadopoulos, KP; Patnaik, A; Siu, LL; Sullivan, DM; Tetteh, E; Tolcher, AW; Vitfell-Rasmussen, J; Yan, L; Zernhelt, AM | 1 |
| Hotta, K; Iwaki, N; Kiura, K; Kubo, T; Minami, D; Morichika, D; Sato-Hisamoto, A; Takata, K; Tanimoto, M; Uchida, K | 1 |
| Albain, KS; Barlow, WE; Budd, GT; Burton, GV; Chew, HK; Cho, JK; Flaherty, LE; Gralow, JR; Hobday, TJ; Hortobagyi, GN; Isaacs, C; Lew, DL; Livingston, RB; McGregor, BA; Moore, HC; Moore, TD; Rinn, KJ; Salim, M; Srkalovic, G; Stewart, JA | 1 |
| Arita, KI; Doi, M; Hattori, N; Kitaguchi, S; Kondo, T; Murakami, I; Nakano, K; Sakurai, J; Yamasaki, M | 1 |
6 trial(s) available for paclitaxel and Febrile Neutropenia
| Article | Year |
|---|---|
Phase I Trial of nab-Paclitaxel Administered Concurrently With Radiotherapy in Patients With Locally Advanced Inoperable Pancreatic Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Albumins; Chemoradiotherapy; Enterocolitis; Febrile Neutropenia; Humans; Middle Aged; Paclitaxel; Pancreatic Neoplasms | 2022 |
Phase I Trial Evaluating the Safety of Preoperative Gemcitabine/nab-Paclitaxel With Concurrent Radiation Therapy for Borderline Resectable Pancreatic Cancer.
Topics: Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Combined Modality Therapy; Deoxycytidine; Febrile Neutropenia; Female; Gemcitabine; Humans; Infections; Male; Middle Aged; Paclitaxel; Pancreatectomy; Pancreatic Neoplasms; Preoperative Period | 2018 |
A retrospective evaluation of chemotherapy dose intensity and supportive care for early-stage breast cancer in a curative setting.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Drug Administration Schedule; Febrile Neutropenia; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Multivariate Analysis; Paclitaxel; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Taxoids | 2013 |
Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Docetaxel; Dose-Response Relationship, Drug; Erlotinib Hydrochloride; Exanthema; Fatigue; Febrile Neutropenia; Female; Heterocyclic Compounds, 3-Ring; Humans; Male; Middle Aged; Nausea; Neoplasms; Paclitaxel; Proto-Oncogene Proteins c-akt; Quinazolines; Stomatitis; Taxoids; Tinnitus; Treatment Outcome; Young Adult | 2014 |
SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Febrile Neutropenia; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Paclitaxel; Proportional Hazards Models; Young Adult | 2015 |
Carboplatin plus Weekly Paclitaxel Combined with Bevacizumab as First-line Treatment for Non-small Cell Lung Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Diarrhea; Disease-Free Survival; Drug Administration Schedule; Febrile Neutropenia; Female; Humans; Infections; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Treatment Outcome; Vomiting | 2017 |
3 other study(ies) available for paclitaxel and Febrile Neutropenia
| Article | Year |
|---|---|
Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy
Topics: Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Esophagogastric Junction; Febrile Neutropenia; Humans; Neoplasm Recurrence, Local; Oxaliplatin; Paclitaxel; Ramucirumab; Retrospective Studies; Stomach Neoplasms | 2023 |
Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer (K-PaC) Registry.
Topics: Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cross-Over Studies; Deoxycytidine; Febrile Neutropenia; Female; Fluorouracil; Gemcitabine; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms; Peripheral Nervous System Diseases; Peritoneal Neoplasms; Progression-Free Survival; Registries; Republic of Korea; Survival Rate; Treatment Outcome | 2020 |
Fatal Candida septic shock during systemic chemotherapy in lung cancer patient receiving corticosteroid replacement therapy for hypopituitarism: a case report.
Topics: Adenoma; Adrenal Cortex Hormones; Aged; Antineoplastic Combined Chemotherapy Protocols; Candidemia; Carboplatin; Fatal Outcome; Febrile Neutropenia; Humans; Hypophysectomy; Hypopituitarism; Lung Neoplasms; Male; Paclitaxel; Pituitary Neoplasms; Shock, Septic | 2014 |